Back to Pharma Services
Curewell Capital
Middle-market PE firm founded 2021, focused exclusively on healthcare services, pharma, medical devices, and healthcare tech; actively investing in CROs, CDMOs, and specialty pharmacy.
Why interesting to a deal team
Counsel serves as repeat deal counsel; demonstrates deep expertise in pharma services investment thesis and add-on acquisition strategy.
Experts connected to this company
Sources
- Structured dataPrimarycurewellcapital.com
- Structured dataPressArchived 2025-10-21businesswire.com/news/home/20251021135557/en/Wilmington-PharmaTech-Continues-Expansion-with-Significant-Investment-from-Curewell-Capital
Strongest evidenceStructured data2 public sourcesHow the grades work